Clinical Trial Update: A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating Hemay022 in combination with an aromatase inhibitor for advanced breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hemay022

Snippet

Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING